These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2901421)

  • 1. The UGI series in renal transplant candidates.
    Lao A; Bach D
    Can Assoc Radiol J; 1988 Sep; 39(3):195-7. PubMed ID: 2901421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptic ulcer disease following renal transplantation in the cyclosporine era.
    Reese J; Burton F; Lingle D; Lindsey L; Aridge D; Fairchild R; Garvin P
    Am J Surg; 1991 Dec; 162(6):558-62. PubMed ID: 1670224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric assessment of prospective renal-transplant patients.
    Gordon EM; Johnson AG; Williams G
    Lancet; 1972 Jan; 1(7744):226-9. PubMed ID: 4109699
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptic ulceration in kidney transplantation.
    Ahonen J; Eklund B; Lindfors O; Kuhlbäck B; Lindström BL
    Proc Eur Dial Transplant Assoc; 1977; 14():396-400. PubMed ID: 23527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of cimetidine to prevent gastroduodenal ulceration and bleeding after renal transplantation.
    Schiessel R; Starlinger M; Wolf A; Pinggera W; Zazgornik J; Schmidt P; Wagner O; Schwarz S; Piza F
    Surgery; 1981 Sep; 90(3):456-8. PubMed ID: 7022726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of immunosuppression on peptic ulceration following renal transplantation and the role of endoscopy.
    Steger AC; Timoney AS; Griffen S; Salem RR; Williams G
    Nephrol Dial Transplant; 1990; 5(4):289-92. PubMed ID: 1972555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulceration in the critically ill patient.
    Knight A; Bihari D; Tinker J
    Br J Hosp Med; 1985 Apr; 33(4):216-9. PubMed ID: 2864094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
    Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer after renal transplantation.
    Lancet; 1979 Feb; 1(8112):366-7. PubMed ID: 85011
    [No Abstract]   [Full Text] [Related]  

  • 11. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant peptic ulcer disease in cardiac surgical patients: pathogenesis, prevention, and management.
    Rosen HR; Vlahakes GJ; Rattner DW
    Crit Care Med; 1992 Mar; 20(3):354-9. PubMed ID: 1347261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine in renal-transplant recipients.
    Hussey JL; Belzer FO
    Lancet; 1979 May; 1(8125):1089-90. PubMed ID: 86817
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P; McCauley DL
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
    Jensen DM
    Am J Med; 1986 Oct; 81(4B):42-8. PubMed ID: 2877574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroduodenal ulceration in renal transplant patients.
    Schweizer RT; Bartus SA
    Conn Med; 1978 Feb; 42(2):85-8. PubMed ID: 343988
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peptic ulcer disease in the renal transplant patient.
    Owens ML; Passaro E; Wilson SE; Gordon HE
    Ann Surg; 1977 Jul; 186(1):17-21. PubMed ID: 327953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.